New drug combo aims to shrink tumors before colon cancer surgery

NCT ID NCT05706779

Recruiting now Disease control Sponsor: Federation Francophone de Cancerologie Digestive Source: ClinicalTrials.gov ↗

Summary

This study is testing whether giving two targeted drugs before surgery can shrink tumors in people with a specific type of colon or upper rectal cancer. It is for patients whose cancer has a BRAF V600E mutation and has not spread. The goal is to see if this pre-surgery treatment leads to significant tumor shrinkage, which may help surgeons remove the cancer more effectively.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu - Hôpital Européen Georges Pompidou
RECRUITING

Paris, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

BRAF V600E MUTATION POSITIVE COLORECTAL CANCER